nanotech investing Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
nanotech investing Cullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Summit
nanotech investing Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024
nanotech investing Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
nanotech investing Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
GMV Minerals Inc. Extends Exclusive Option to Acquire Mexican Hat Mining Claims - Commissions Updated Preliminary Economic Assessment
Blue Sky Hosts Community and Stakeholder Water Sampling Event at the Ivana Uranium-Vanadium Project, Argentina
E-Power Resources Inc. Announces Flow-Through and Hard Dollar Private Placements to Fund Summer Work Program
Juggernaut Exploration: Advancing High-grade Precious Metals Assets in Northern BC’s Golden Triangle
